Product Information
INTEGRA F CAPSULE is a brand product labeled by U.S. Pharmaceutical Corporation, priced at $0.6185 per EA under NDC 52747071130. Its NADAC has been published 395 times since Nov 28, 2013.
Strength
40; 62.5; 62.5; 1; 3 mg/1; mg/1; mg/1; mg/1; mg/1
Manufacturer
U.S. Pharmaceutical CorporationNDC
52747071130
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
10/1/2026
Approval Type
Unapproved
On Market Since
4/27/2009
Pharmacological Classes
Price Statistics
The NADAC for INTEGRA F CAPSULE has been published 395 times since Nov 28, 2013, and over the history we have for it it has risen 36.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6185 per EA |
|---|---|
| All-time high | $0.6185 (Sep 30, 2026) |
| All-time low | $0.4523 (Nov 28, 2013) |
| 52-week high | $0.6185 |
| 52-week low | $0.5607 |
| Median price | $0.4975 |
| Average price | $0.4980 |
| Largest weekly change | +11.8% (Mar 18, 2026) |
| Weeks tracked | 395 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Weekly brief
Featured in the latest weekly brief
This NDC appears in the current executive summary of the most important weekly NADAC moves.
Manufacturer
U.S. Pharmaceutical Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ferrous Fumarate and Polysacchride Iron Complex and Folic Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nicotinic Acid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of INTEGRA F CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for INTEGRA F CAPSULE, manufactured by U.S. Pharmaceutical Corporation, is $0.6185 per EA (NDC 52747071130), effective Sep 30, 2026.
How has the price of INTEGRA F CAPSULE changed over time?
Over the history we have for it, the NADAC for INTEGRA F CAPSULE has risen 36.8%. It has been tracked across 395 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for INTEGRA F CAPSULE?
Since Nov 28, 2013, the NADAC for INTEGRA F CAPSULE has ranged from a low of $0.4523 (Nov 28, 2013) to a high of $0.6185 (Sep 30, 2026), with a median of $0.4975 per EA.
Are there cheaper alternatives to INTEGRA F CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INTEGRA F CAPSULE, is $0.5699 per EA — about 8% below INTEGRA F CAPSULE.
Who manufactures INTEGRA F CAPSULE?
INTEGRA F CAPSULE (NDC 52747071130) is labeled by U.S. Pharmaceutical Corporation, and CMS classifies it as a brand product.